65086 Federal Register / Vol. 62, No. 237 / Wednesday, December 10, 1997 / Notices

1. Program Characteristics:

Objectives, design, and direction of

the research training program—

including the probability of achieving

stated goals.

Substantive and methodological

content of the proposed program and its

relevance to the Program Objectives

noted above, including relevant

descriptions of courses and experiential

opportunities offered and/or required.

The extent to which proposed

approaches address areas in need of

research given changes in the health

care delivery system.

2. Program Support and Organizational

Structure and Plans

The institutional training

environment, including the level of

institutional commitment, quality of the

facilities, availability of appropriate

courses, and availability of research

support.

Caliber of preceptors as researchers,

including successful research support;

Organizational structure of the

proposed training program, including

delineation of administrative

responsibilities for planning, oversight,

and evaluation.

Demonstration of cooperation by any

proposed collaborating facilities,

institutions, or departments in

providing research experiences and/or

sites for trainees, including (where

applicable) documentation of

mechanisms by which trainees will be

integrated into the ongoing primary

medical care research activities of other

entities.

When appropriate, the concomitant

research training of health-professional

postdoctorates (e.g., individuals with

the M.D., D.O., D.D.S./D.M.D., etc.) with

basic science postdoctorates (e.g.,

individuals with a Ph.D., etc.) or

linkages with basic science department.

Demonstration of extent to which and

ways in which HRSA support will be

(has been in the past) leveraged through

the use of other Federal and private

resources to maximize primary medical

care research training within the

institution.

Availability of other relevant support.

3. Trainee Recruitment & Retention

Plans

Recruitment and selection plans for

trainees and the availability of highquality candidates, including minority

trainees (see below for details).

When appropriate, record of the

research training program in retaining

health-professional postdoctoral

trainees for at least 2 years in research

training or other research activities.

4. Program Record and Evaluation Plans

Past research training record of both

the program and the designated

preceptors as determined by the success

of former trainees in seeking further

career development and in establishing

productive scientific careers. Evidence

of further career development can

include receipt of fellowships, career

awards, a prestigious training

appointment, and similar

accomplishments. Evidence of a

productive scientific career can include

a record of successful competition for

individual research grants, receipt of

special honors, a record of publications,

receipt of patents, promotion to

prestigious positions in academe,

industry, or health policy and any other

appropriate measure of success

consistent with the nature and duration

of the training received.

Record of the research training

program in recruiting and retaining

trainees, noting past annual success

rates in filling committed slots.

Proposed methods for monitoring and

evaluating performance of trainees and

the overall program, record of trainees

in obtaining individual research awards

or fellowships following training, and in

establishing careers in primary medical

care research.

5. Budget

Reasonableness of the proposed

budget, including number and levels of

trainees, in relation to the research

training.

For additional information, please

contact: Enrique Fernandez, M.D.,

Division of Medicine, Bureau of Health

Professions, Health Resources and

Services Administration, Parklawn

Building, Room 9A–20, 5600 Fishers

Lane, Rockville, Maryland 20857,

Telephone : (301) 443–1467, FAX: (301)

443–8890.

Dated: December 3, 1997.

Claude Earl Fox,

Acting Administrator.

[FR Doc. 97–32279 Filed 12–9–97; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration

Final Review Criterion for Grants for

Primary Care Training Programs for

Fiscal Year 1998

Grants for Primary Care Training

programs are authorized under sections

747(a) and (b), 748, 750 and 751, title

VII of the Public Health Service Act, as

amended by the Health Professions

Education Extension Amendments of

1992, Pub. L. 102–408, dated October

13, 1992. These grant programs include:

Grants for Predoctoral Training in Family

Medicine

Grants for Faculty Development in Family

Medicine

Grants for Graduate Training in Family

Medicine

Grants for Establishment of Departments of

Family Medicine

Grants for Residency Training in General

Internal Medicine and General Pediatrics

Grants for Faculty Development in General

Internal Medicine and General Pediatrics

Grants for Physician Assistant Training

Grants for Podiatric Primary Care Residency

Training

A notice was published in the Federal

Register at 62 FR 46502 on September

3, 1997, for a review criterion for the

above-referenced programs. No

comments were received within the 30

day comment period. Therefore, the

review criterion remains as proposed.

Final Review Criterion

The following criterion has been

added to the existing review criteria

established in 61 FR 52034 on October

4, 1996:

5. Project impact/influence in shaping

the curriculum, program, department,

institution and the community.

The review criterion is finalized in

this combined notice, rather than

individual program announcements, to

provide consistent review of all primary

care medical education grant

applications.

If additional information is needed,

please contact: Enrique Fernandez,

M.D., Division of Medicine, Bureau of

Health Professions, Health Resources

and Services Administration, Parklawn

Building, Room 9A–20, 5600 Fishers

Lane, Rockville, Maryland 20857,

Telephone: (301) 443–1467, FAX: (301)

443–8890.

Dated: December 4, 1997.

Claude Earl Fox,

Acting Administrator.

[FR Doc. 97–32280 Filed 12–9–97; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration

National Vaccine Injury Compensation

Program; List of Petitions Received

AGENCY: Health Resources and Services

Administration, HHS.

ACTION: Notice.
Federal Register / Vol. 62, No. 237 / Wednesday, December 10, 1997 / Notices 65087

SUMMARY: The Health Resources and

Services Administration (HRSA) is

publishing this notice of petitions

received under the National Vaccine

Injury Compensation Program (‘‘the

Program’’), as required by section

2112(b)(2) of the Public Health Service

(PHS) Act, as amended. While the

Secretary of Health and Human Services

is named as the respondent in all

proceedings brought by the filing of

petitions for compensation under the

Program, the United States Court of

Federal Claims is charged by statute

with responsibility for considering and

acting upon the petitions.

FOR FURTHER INFORMATION CONTACT: For

information about requirements for

filing petitions, and the Program

generally, contact the Clerk, United

States Court of Federal Claims, 717

Madison Place, N.W., Washington, D.C.

20005, (202) 219–9657. For information

on HRSA’s role in the Program, contact

the Director, National Vaccine Injury

Compensation Program, 5600 Fishers

Lane, Room 8A35, Rockville, MD 20857,

(301) 443–6593.

SUPPLEMENTARY INFORMATION: The

Program provides a system of no-fault

compensation for certain individuals

who have been injured by specified

childhood vaccines. Subtitle 2 of title

XXI of the PHS Act, 42 U.S.C. 300aa–

10 et seq., provides that those seeking

compensation are to file a petition with

the U.S. Court of Federal Claims and to

serve a copy of the petition on the

Secretary of Health and Human

Services, who is named as the

respondent in each proceeding. The

Secretary has delegated her

responsibility under the Program to

HRSA. The Court is directed by statute

to appoint special masters who take

evidence, conduct hearings as

appropriate, and make initial decisions

as to eligibility for, and amount of,

compensation.

A petition may be filed with respect

to injuries, disabilities, illnesses,

conditions, and deaths resulting from

vaccines described in the Vaccine Injury

Table (the Table) set forth at section

2114 of the PHS Act or as set forth at

42 CFR 100.3, as applicable. This Table

lists for each covered childhood vaccine

the conditions which will lead to

compensation and, for each condition,

the time period for occurrence of the

first symptom or manifestation of onset

or of significant aggravation after

vaccine administration. Compensation

may also be awarded for conditions not

listed in the Table and for conditions

that are manifested after the time

periods specified in the Table, but only

if the petitioner shows that the

condition was caused by one of the

listed vaccines.

Section 2112(b)(2) of the PHS Act, 42

U.S.C. 300aa–12(b)(2), requires that the

Secretary publish in the Federal

Register a notice of each petition filed.

Set forth below is a list of petitions

received by HRSA on July 2, 1997,

through September 29, 1997.

Section 2112(b)(2) also provides that

the special master ‘‘shall afford all

interested persons an opportunity to

submit relevant, written information’’

relating to the following:

1. The existence of evidence ‘‘that

there is not a preponderance of the

evidence that the illness, disability,

injury, condition, or death described in

the petition is due to factors unrelated

to the administration of the vaccine

described in the petition,’’ and

2. Any allegation in a petition that the

petitioner either:

(a) ‘‘Sustained, or had significantly

aggravated, any illness, disability,

injury, or condition not set forth in the

Table but which was caused by’’ one of

the vaccines referred to in the Table, or

(b) ‘‘Sustained, or had significantly

aggravated, any illness, disability,

injury, or condition set forth in the

Table the first symptom or

manifestation of the onset or significant

aggravation of which did not occur

within the time period set forth in the

Table but which was caused by a

vaccine’’ referred to in the Table.

This notice will also serve as the

special master’s invitation to all

interested persons to submit written

information relevant to the issues

described above in the case of the

petitions listed below. Any person

choosing to do so should file an original

and three (3) copies of the information

with the Clerk of the U.S. Court of

Federal Claims at the address listed

above (under the heading FOR FURTHER

INFORMATION CONTACT), with a copy to

HRSA addressed to Director, Bureau of

Health Professions, 5600 Fishers Lane,

Room 8–05, Rockville, MD 20857. The

Court’s caption (Petitioner’s Name v.

Secretary of Health and Human

Services) and the docket number

assigned to the petition should be used

as the caption for the written

submission.

Chapter 35 of title 44, United States

Code, related to paperwork reduction,

does not apply to information required

for purposes of carrying out the

Program.

List of Petitions

1. Brenda Scott-Sheppard, Boston,

Massachusetts, Court of Federal

Claims Number 97–0449 V

2. Joann O’Loughlin, Fremont,

California, Court of Federal Claims

Number 97–0458 V

3. Melody and John Harris on behalf of

Christina Harris, San Mateo,

California, Court of Federal Claims

Number 97–0470 V

4. Anne M. Nagel, Little Falls,

Minnesota, Court of Federal Claims

Number 97–0479 V

5. Debra Graham Robert, Birmingham,

Alabama, Court of Federal Claims

Number 97–0501 V

6. Betty and Freeman Wingard on behalf

of Lori Beth Wingard, LaGrange,

Indiana, Court of Federal Claims

Number 97–0502 V

7. Tatyana and Alex Vainshelboim on

behalf of Jane Vainshelboim,

Morganville, New Jersey, Court of

Federal Claims Number 97–0516 V

8. Hans J. Herkert on behalf of John

Henry Herkert, Cold Spring, New

York, Court of Federal Claims Number

97–0518 V

9. Abhinav and Mija Le Trehan on

behalf of Daniel Lee Trehan, Kansas

City, Missouri, Court of Federal

Claims Number 97–0528 V

10. Ellen and Charles Eiss on behalf of

Gabrielle Eiss, Coral Springs, Florida,

Court of Federal Claims Number 97–

0529 V

11. Elham Rafla-Yuan, Tampa, Florida,

Court of Federal Claims Number 97–

0531 V

12. John R. Kline, Buffalo, New York,

Court of Federal Claims Number 97–

0535 V

13. Lino Delgado and Gricer Diaz on

behalf of Coralys Gricer Delgado-Diaz,

Rio Piedras, Puerto Rico, Court of

Federal Claims Number 97–0538 V

14. Pauline Fadelalla, New York, New

York, Court of Federal Claims Number

97–0573 V

15. Robin D. Blankenship, Ocala,

Florida, Court of Federal Claims

Number 97–0574 V

16. Madeline H. and William F.

Warnock, Jr. on behalf of Benjamin

Perry Warnock, Alexandria, Virginia,

Court of Federal Claims Number 97–

0585 V

17. Cynthia Peters on behalf of Kendall

P. Lumsden, Cary, North Carolina,

Court of Federal Claims Number 97–

0588 V

18. Mary Alice Nanney, Brandon,

Mississippi, Court of Federal Claims

Number 97–0590 V

19. Shannon E. Casey, Vienna, Virginia,

Court of Federal Claims Number 97–

0612 V

20. Tracy Lynn Nichols on behalf of

Shelby Nichols, Angier, North

Carolina, Court of Federal Claims

Number 97–0625 V

21. Nikki and David McColm on behalf

of Nicholas Vernon McColm, Astoria,
65088 Federal Register / Vol. 62, No. 237 / Wednesday, December 10, 1997 / Notices

Oregon, Court of Federal Claims

Number 97–0631 V

22. Kim and Daniel Olexiewicz on

behalf of Jason Olexiewicz, Deceased,

Encino, California, Court of Federal

Claims Number 97–0638 V

23. Frances and James DeRoche on

behalf of John-Paul D. DeRoche, La

Canada, California, Court of Federal

Claims Number 97–0643 V

24. Dawn and Douglas Biron on behalf

of Thomas J. Biron, Chisago,

Minnesota, Court of Federal Claims

Number 97–0651 V

Dated: December 4, 1997.

Claude Earl Fox,

Acting Administrator.

[FR Doc. 97–32278 Filed 12–9–97; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Public Health Service

Centers for Disease Control and

Prevention; Statement of Organization,

Functions, and Delegations of

Authority

Part C (Centers for Disease Control

and Prevention) of the Statement of

Organization, Functions, and

Delegations of Authority of the

Department of Health and Human

Services (45 FR 67772–76, dated

October 14, 1980, and corrected at 45 FR

69296, October 20, 1980, as amended

most recently at 62 FR 53649, dated

October 15, 1997) is amended to reflect

the establishment of VaccinePreventable Disease Eradication

Division (VPDED) and the abolishment

of the Polio Eradication Activity within

National Immunization Program (NIP),

Centers for Disease Control and

Prevention (CDC). The functional

statement for the Office of the Director,

NIP, is being revised to be consistent

with the subject reorganization.

Section C–B, Organization and

Functions, is hereby amended as

follows:

Revise the functional statement for

the Office of the Director (CJ1), National

Immunization Program (CJ), as follows:

Delete item (11) and renumber the

remaining items accordingly. Delete the

function for item (12) and insert the

following: Serves as the principal CDC

focus for liaison and coordination with

other Department of Health and Human

Services operating divisions and staff

offices, federal agencies, state, and local

health authorities, and public and

private organizations concerned with

immunization activities.

Delete in their entirety the title and

functional statement for the Polio

Eradication Activity (CJ12).

After the functional statement for the

Communicty Outreach and Planning

Branch (CJ45), insert the following:

Vaccine-Preventable Disease

Eradication Division (CJ5). (1) Provides

national leadership and coordination of

the National Immunization Program

(NIP) efforts to eradicate polio, measles,

and other vaccine-preventable diseases

(VPDs) which may be targeted for

eradication in the future, in

collaboration with the World Health

Organization (WHO) and its regional

officer, UNICEF, Rotary International,

USAID, other international

organizations and agencies, and CDC

Centers/Institute/Offices (CIOs); (2)

provides short- and long-term

consultation and technical assistance to

WHO, UNICEF, and foreign countries

involved in the global eradication of

polio and measles and participates in

international advisory group meetings

regarding polio and measles eradication;

(3) administers grants to WHO, UNICEF,

and other international partners as

appropriate for the provision of

technical, programmatic, and laboratory

support, and vaccine procurement for

initiatives to eradicate polio, measles,

and other VPDs; (4) designs and

participates in international research,

monitoring, and evaluation projects to

increase the effectiveness of polio,

measles, and other eradication strategies

as may be developed; (5) develops

strategies to improve the technical skills

and problem-solving abilities of

program managers and health care

workers in other countries; (6) refines

strategies developed for the eradication

of polio and measles in the Western

Hemisphere for implementation in other

parts of the world; (7) assists other

countries in projects to improve

surveillance for polio, measles, and

other VPDs, including development of

computerized systems for disease

monitoring; (8) assists WHO, UNICEF,

and other partner organizations in

strengthening global epidemiologic and

laboratory surveillance for polio,

measles, and other VODs targeted for

eradication; (9) prepares articles based

on findings for publication in

international professional journals and

presentation at international

conferences; (10) collaborates with other

countries, WHO, UNICEF, and advocacy

groups, to ensure the availability of

sufficient funds to purchase an adequate

supply of polio and measles vaccine,

and funds for technical support, for use

in polio and measles eradication efforts.

Office of the Director (CJ51). (1)

Manages, directs, and coordinates the

activities of the division; (2) provides

leadership in policy formation, program

planning and development, program

management, and operations of the

division; (3) identifies needs and

resources for new initiatives and assigns

responsibilities for their development;

(4) oversees the division’s activities and

expenditures; (5) serves as the principal

CDC focus for liaison and coordination

on VPD eradication programs with CDC

CIOs, other federal agencies,

international organizations, foreign

governments, and other organizations

concerned with VPD eradication.

(Program Operations Branch (CJ52).

(1) Plans, coordinates, and directs

programmatic activities in NIP to

eradicate polio, measles, and other

VPDs; (2) provides short- and long-term

programmatic assistance to WHO,

UNICEF, and foreign countries involved

in the global eradication of polio and

measles and participates in

international advisory group meetings

regarding polio and measles eradication;

(3) administers grants to UNICEF and

WHO for provision of technical,

programmatic, and laboratory support,

and vaccine procurement; (4) provides

administrative and programmatic

support to all staff including staff

assigned outside of the Atlanta area; (5)

provides oversight of budget and

accounting services for the division; (6)

develops and implements disease

eradication training courses for staff

from CDC, WHO, UNICEF, Rotary

International, and other immunization

partners; (7) coordinates advocacy

activities with Rotary International,

USAID, WHO, UNICEF, and other global

partners to ensure the availability of

adequate resources for polio, measles,

and other VPD eradication activities.

Technical Services Branch (CJ53). (1)

Plans, coordinates, and directs technical

activities related to NIP efforts to

eradicate polio, measles, and other

VPDs, in collaboration with the WHO

and its regional offices, UNICEF, Rotary

International, USAID, other

international organizations and

agencies, and other CDC CIOs; (2)

provides short- and long-term

consultation and technical assistance to

WHO, UNICEF, and foreign countries

involved in the global eradication of

polio and measles and participates in

international advisory group meetings

regarding polio and measles eradication;

(3) designs and participates in

international research, monitoring, and

evaluation projects to increase the

effectiveness of polio and measles

eradication strategies; (4) develops

strategies to improve the technical skills

and problem-solving abilities of

program managers and health care